These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 17163187)

  • 1. [Tuberculosis in Poland, Europe, and world. Part II--mortality, drug resistance and HIV infection].
    Zielonka TM
    Pol Merkur Lekarski; 2006 Sep; 21(123):253-61. PubMed ID: 17163187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis and the HIV pandemic. Risk of nosocomial tuberculosis infection].
    Pedersen C; Kolmos HJ; Nielsen JO
    Ugeskr Laeger; 1997 Feb; 159(9):1233-8. PubMed ID: 9072866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis in Europe: a problem of drug resistance or much more?
    Carvalho AC; Migliori GB; Cirillo DM
    Expert Rev Respir Med; 2010 Apr; 4(2):189-200. PubMed ID: 20406085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculosis in Poland, Europe, and world. Part I--prevalence].
    Zielonka TM
    Pol Merkur Lekarski; 2006 Sep; 21(123):243-52. PubMed ID: 17163186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.
    De Cock KM; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):457-65. PubMed ID: 10383056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis, a re-emergent disease.
    Valadas E; Antunes F
    Eur J Radiol; 2005 Aug; 55(2):154-7. PubMed ID: 15905058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global aspects of tuberculosis in children.
    Datta M; Swaminathan S
    Paediatr Respir Rev; 2001 Jun; 2(2):91-6. PubMed ID: 12531054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tuberculosis in Europe and Poland--new molecular families and new resistance patterns].
    Augustynowicz-Kopeć E; Zwolska Z
    Przegl Epidemiol; 2008; 62(1):113-21. PubMed ID: 18536233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Global situation of TB and its control].
    Shimao T
    Kekkaku; 1999 Feb; 74(2):83-90. PubMed ID: 10191600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
    Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
    J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tuberculosis and its control--lessons from the past and future prospect].
    Shimao T
    Kekkaku; 2005 Jun; 80(6):481-9. PubMed ID: 16130906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.
    Corbett EL; Watt CJ; Walker N; Maher D; Williams BG; Raviglione MC; Dye C
    Arch Intern Med; 2003 May; 163(9):1009-21. PubMed ID: 12742798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis control in India--past, present and future.
    Prabhakar R
    J Indian Med Assoc; 2000 Mar; 98(3):123-5. PubMed ID: 11016168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model.
    Atun RA; Lebcir R; Drobniewski F; Coker RJ
    Int J STD AIDS; 2005 Aug; 16(8):560-70. PubMed ID: 16105192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TB pandemic: an old problem seeking new solutions.
    Meya DB; McAdam KP
    J Intern Med; 2007 Apr; 261(4):309-29. PubMed ID: 17391107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.